Williams B T, Kumar R, Klinger H. "一种的合成方法" [P]. US Patent, US 11083778 B2, 2016-07-17.
Klinger H, Kumar R, Yamamoto T. "Method for the Synthesis of 2-(3-(Chloromethyl)piperidin-1-yl)-6-methylpyrazine" [P]. US Patent, US 11233828 B2, 2025-04-02.
发明人朱建伟,罗永刚,赵玉洁. "A Process for Preparing High-Purity 2-(3-(Chloromethyl)piperidin-1-yl)-6-methylpyrazine" [P]. 中国发明专利, 专利号 CN 110154348 B, 授权公告日 2016-12-06.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2017, 711, 7653-7676.
Hughes D, Roberts J, Thomas A. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2011, 1741, (12), 7360-7374.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 2-(3-(Chloromethyl)piperidin-1-yl)-6-methylpyrazine Using HRMS and NMR". Food Chem., 2016, 708, (12), 8529-8555.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2015, 2245, 3346-3354.